Category: Clinical
Post
FHC, Inc. Announces EU MDR Certification of ATLAS™ Neurophysiology System
Bowdoinham, ME — June 10, 2026 — FHC, Inc., a leading manufacturer of precision medical devices for neurosurgery and neuroscience…Post
Announcing the NeuraLynx ATLAS Stim Headbox
We’re proud to announce that our ATLAS Stimulation Headbox has officially received 510(k) clearance from the FDA! The ATLAS Stim…Post
Revolutionizing Pre-Operative Planning for STarFix Procedures
Introducing STarFix™ Designer: Revolutionizing Pre-Operative Planning for STarFix Procedures Bowdoin, ME – FHC, Inc. proudly announces the launch of STarFix…Post
FHC Sponsoring WIRED: Epilepsy & DBS
FHC, Inc. and NeuraLynx (an FHC Company) Will be sponsoring and exhibiting at the Third Edition of WIRED (Workshop on…Post
FHC and NeuraLynx Exhibiting at AES
FHC, Inc. and NeuraLynx (an FHC Company), will be exhibiting at AES’s Annual Meeting December 1st through the 5th at the…Post
New NeuraLynx Website Launch
After the acquisition of Neuralynx into FHC’s family of brands, we are launching a new Neuralynx website! This rebuilt web…Post
FHC Exhibiting at ESSFN
FHC, Inc. will be exhibiting at the 25th Congress of the European Society for Stereotactic and Functional Neurosurgery in Stockholm,…Post
New Guideline 5 Software Update
The Guideline 5 software update to version 2.2.0 includes minor enhancements and bug fixesincluding the following: Power Spectral Density…Post
FHC Launches New STarFix Direct Website
FHC is excited to announce the launch of our new STarFix Direct website, offering a new robust and user-friendly way…Post